首页> 外文期刊>Journal of oral pathology and medicine: Official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology >Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome
【24h】

Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome

机译:芦荟,巴巴德芦荟的前瞻性,随机,双盲临床评估,结合护舌剂治疗烧灼口综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The aim of this study was to evaluate the efficacy of aloe vera (AV) applied in combination with a tongue protector, comparing this with a placebo. Methods: A total of 75 patients with burning mouth syndrome (BMS) were divided into three groups randomly: Group I (tongue protector three times a day), Group II (tongue protector and 0.5 ml AV at 70% three times a day) and Group III (tongue protector and 0.5 ml placebo three times a day). Symptoms were evaluated by visual analogue scale (VAS), while patient psychological profiles were assessed using the Hospital Anxiety-Depression scale and their quality of life using the Oral Health Impact Profile 49 (OHIP-49). Treatment continued for 3 months. Results: Visual analogue scale pain values improved for all three study groups but without statistically significant differences between the groups (P = 0.210). Regarding quality of life, no significant differences were found between groups with the exception of the OHIP-49 score for handicap. The overall clinical improvement was greater for Group II, with a difference almost reaching significance. Conclusions: The concomitant prescription of tongue protector and AV is effective for treating patients with BMS.
机译:目的:这项研究的目的是评估芦荟(AV)与舌头保护剂联合使用的功效,并将其与安慰剂进行比较。方法:将75例烧嘴综合征(BMS)患者随机分为三组:第一组(每天3次舌保护剂),第二组(每天70%的舌保护剂和0.5 ml的AV 3次)和第三组(舌部保护剂和0.5毫升安慰剂,每天3次)。通过视觉模拟量表(VAS)评估症状,同时使用医院焦虑抑郁量表评估患者的心理状况,并通过口腔健康影响状况表49(OHIP-49)评估患者的生活质量。治疗持续了3个月。结果:三个研究组的视觉模拟量表疼痛值均得到改善,但各组之间无统计学差异(P = 0.210)。关于生活质量,除残障人士的OHIP-49得分外,各组之间没有发现显着差异。第二组的整体临床改善更大,差异几乎达到显着水平。结论:舌头保护器和AV并用可有效治疗BMS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号